Sensitization in Heart Transplantation Emerging Knowledge
Published: February 19, 2019
- Sensitization, defined as the presence of circulating human leukocyte antigen (HLA) antibodies, presents challenges for heart transplant recipients and physicians.
- The presence of sensitization in transplant patients can delay or restrict access to organ transplantation.
- Sensitization can impact morbidity and mortality of the patient awaiting transplant or the patient with transplant.
Supporting Materials
Related Resources
Related Science
- Antibody Mediated Rejection in Cardiac Transplantation: Emerging Knowledge in Diagnosis and Management
- Evaluation and Management of Right Sided Heart Failure
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and community Patient Care